Curcumin attenuates cyclosporine A‑induced renal fibrosis by inhibiting hypermethylation of the klotho promoter

Hu,Ying; Mou,Lijun; Yang,Fuye; Tu,Haiyan; Lin,Wanbing

doi:10.3892/mmr.2016.5601

Curcumin attenuates cyclosporine A‑induced renal fibrosis by inhibiting hypermethylation of the klotho promoter

Authors:
- Ying Hu
- Lijun Mou
- Fuye Yang
- Haiyan Tu
- Wanbing Lin
View Affiliations

Affiliations: Department of Nephrology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 31009, P.R. China
Published online on: August 8, 2016 https://doi.org/10.3892/mmr.2016.5601
Pages: 3229-3236

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic kidney disease is increasingly considered to be a worldwide public health problem and usually leads to renal fibrosis. In the present study, curcumin, a polyphenol pigment extracted from turmeric, was demonstrated to exert protective effects on renal fibrosis via the suppression of transforming growth factor‑β (TGF‑β) downstream signaling, such as plasminogen activator inhibitor‑1 (PAI‑1), α‑smooth muscle actin (α‑SMA) and collagen I (Col I) downregulation. The present findings demonstrate that curcumin exerted a protective effect on cyclosporine A‑induced renal fibrosis via a klotho (KL)‑dependent mechanism, which inhibits the TGF‑β signaling pathway. Further research indicated that curcumin induced KL expression in HK‑2 tubular epithelial cells by inhibiting CpG hypermethylation in the KL promoter, which mediates the loss of expression in cells. Methylation‑specific polymerase chain reaction (PCR) combined with bisulfite sequencing identified numerous key CpG sites, such as 249, 240 and 236, whose methylation statuses are important for KL expression. A PCR reporter assay was utilized to further confirm these findings. In addition, the effects of curcumin on the regulation of DNA methyltransferase 1 (Dnmt1) expression were evaluated, and the data suggest that curcumin inhibits Dnmt1 expression and restricts CpG hypermethylation. Thus, the current study reveals that curcumin attenuated renal fibrosis by suppressing CpG methylation in the KL promoter, thus inducing KL expression, which inhibited TGF‑β signaling, which may provide a novel therapeutic approach for the treatment of renal fibrosis.

View Figures

View References

1	James MT, Hemmelgarn BR and Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet. 375:1296–1309. 2010. View Article : Google Scholar : PubMed/NCBI
2	Global, regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global burden of disease study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar
3	Levey AS and Coresh J: Chronic kidney disease. Lancet. 379:165–180. 2012. View Article : Google Scholar
4	Garrido P, Ribeiro S, Fernandes J, Vala H, Bronze-da-Rocha E, Rocha-Pereira P, Belo L, Costa E, Santos-Silva A and Reis F: Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model. PLoS One. 10:e01240482015. View Article : Google Scholar : PubMed/NCBI
5	Sinha AD and Agarwal R: Chronic renal disease progression: treatment strategies and potassium intake. Semin Nephrol. 33:290–299. 2013. View Article : Google Scholar : PubMed/NCBI
6	Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY and Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet. 382:260–272. 2013. View Article : Google Scholar : PubMed/NCBI
7	Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ and Nguyen TQ: Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat Rev Nephrol. 11:233–244. 2015. View Article : Google Scholar : PubMed/NCBI
8	Kriz W, Kaissling B and Le Hir M: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy? J Clin Invest. 121:468–474. 2011. View Article : Google Scholar : PubMed/NCBI
9	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
10	Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 390:45–51. 1997. View Article : Google Scholar : PubMed/NCBI
12	Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, et al: Suppression of aging in mice by the hormone Klotho. Science. 309:1829–1833. 2005. View Article : Google Scholar : PubMed/NCBI
13	Sugiura H, Yoshida T, Shiohira S, Kohei J, Mitobe M, Kurosu H, Kuro-o M, Nitta K and Tsuchiya K: Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol. 302:F1252–F1264. 2012. View Article : Google Scholar : PubMed/NCBI
14	Hu MC, Kuro-o M and Moe OW: Renal and extrarenal actions of Klotho. Semin Nephrol. 33:118–129. 2013. View Article : Google Scholar : PubMed/NCBI
15	Azuma M, Koyama D, Kikuchi J, Yoshizawa H, Thasinas D, Shiizaki K, Kuro-o M, Furukawa Y and Kusano E: Promoter methylation confers kidney-specific expression of the Klotho gene. FASEB J. 26:4264–4274. 2012. View Article : Google Scholar : PubMed/NCBI
16	Lee J, Jeong DJ, Kim J, Lee S, Park JH, Chang B, Jung SI, Yi L, Han Y, Yang Y, et al: The anti-aging gene Klotho is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer. 9:1092010. View Article : Google Scholar : PubMed/NCBI
17	Rubinek T, Shulman M, Israeli S, Bose S, Avraham A, Zundelevich A, Evron E, Gal-Yam EN, Kaufman B and Wolf I: Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Res Treat. 133:649–657. 2012. View Article : Google Scholar
18	Srivastava RM, Singh S, Dubey SK, Misra K and Khar A: Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol. 11:331–341. 2011. View Article : Google Scholar
19	Hu Y, Liang H, Du Y, Zhu Y and Wang X: Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells. Am J Nephrol. 31:332–341. 2010. View Article : Google Scholar : PubMed/NCBI
20	Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, He S, Mo X, Chiu M, Wang QE, et al: Curcumin down-regulates DNA meth-yltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One. 8:e559342013. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Cai W, Du A, Feng K, Zhao X, Qian L, Ostrom RS and Xu C: Adenylyl cyclase 6 activation negatively regulates TLR4 signaling through lipid raft-mediated endocytosis. J Immunol. 191:6093–6100. 2013. View Article : Google Scholar : PubMed/NCBI
23	Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E and Dubois-Xu YC: Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients. J Am Soc Nephrol. 22:1375–1381. 2011. View Article : Google Scholar : PubMed/NCBI
24	Damiano S, Scanni R, Ciarcia R, Florio S and Capasso G: Regulation of sodium transporters in the kidney during cyclosporine treatment. J Nephrol. 23(Suppl 16): S191–S198. 2010.
25	Neria F, Castilla MA, Sanchez RF, Gonzalez Pacheco FR, Deudero JJ, Calabia O, Tejedor A, Manzarbeitia F, Ortiz A and Caramelo C: Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney Int. 75:227–234. 2009. View Article : Google Scholar
26	Yoon HE, Ghee JY, Piao S, Song JH, Han DH, Kim S, Ohashi N, Kobori H, Kuro-o M and Yang CW: Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant. 26:800–813. 2011. View Article : Google Scholar :
27	Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, Shiizaki K, Gotschall R, Schiavi S, Yorioka N, et al: Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 286:8655–8665. 2011. View Article : Google Scholar : PubMed/NCBI
28	Sun CY, Chang SC and Wu MS: Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int. 81:640–650. 2012. View Article : Google Scholar : PubMed/NCBI
29	Khan M, Shobha JC, Mohan IK, Rao Naidu MU, Prayag A and Kutala VK: Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. J Appl Toxicol. 26:444–451. 2006. View Article : Google Scholar : PubMed/NCBI
30	Shing CM, Adams MJ, Fassett RG and Coombes JS: Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro. Nutrition. 27:967–972. 2011. View Article : Google Scholar : PubMed/NCBI
31	Moreillon JJ, Bowden RG, Deike E, Griggs J, Wilson R, Shelmadine B, Cooke M and Beaujean A: The use of an anti-inflammatory supplement in patients with chronic kidney disease. J Complement Integr Med. 10:143–152. 2013. View Article : Google Scholar
32	Yamada K, Doi S, Nakashima A, Kawaoka K, Ueno T, Doi T, Yokoyama Y, Arihiro K, Kohno N and Masaki T: Expression of age-related factors during the development of renal damage in patients with IgA nephropathy. Clin Exp Nephrol. 19:830–837. 2015. View Article : Google Scholar
33	Lim JH, Kim EN, Kim MY, Chung S, Shin SJ, Kim HW, Yang CW, Kim YS, Chang YS, Park CW and Choi BS: Age-associated molecular changes in the kidney in aged mice. Oxid Med Cell Longev. 2012:1713832012. View Article : Google Scholar
34	Kliem C, Merling A, Giaisi M, Köhler R, Krammer PH and Li-Weber M: Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation. J Biol Chem. 287:10200–10209. 2012. View Article : Google Scholar : PubMed/NCBI
35	Han DH, Piao SG, Song JH, Ghee JY, Hwang HS, Choi BS, Kim J and Yang CW: Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation. 90:135–141. 2010. View Article : Google Scholar : PubMed/NCBI
36	Mohan KN and Chaillet JR: Cell and molecular biology of DNA methyltransferase 1. Int Rev Cell Mol Biol. 306:1–42. 2013. View Article : Google Scholar : PubMed/NCBI